Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1111-1120 of 2859 for cancer

Edit search filters
  1. (Peak) A Phase 3 Randomized Trial Of CGT9486+Sunitinib Vs. Sunitinib In Subjects With Gastrointestinal Stromal Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. XmAb18968 (CD3-CD38) In Relapsed Or Refractory Acute Leukemia And T Cell Lymphoblastic Leukemia

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Pazopanib In Treating Patients With Metastatic Non-Clear Cell Kidney Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Chemotherapy Alone Or Chemotherapy Plus Radiation Therapy In Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

    Mankato, MN

  5. A Study To Evaluate AFPᶜ³³²T In Advanced HCC

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. S1011 Standard Or Extended Pelvic Lymphadenectomy In Treating Patients Undergoing Surgery For Invasive Bladder Cancer

    Rochester, MN

  7. Quantitative Transmission Imaging Compared With MRI As Supplemental Screening For High Lifetime Risk Of Breast Cancer

    Rochester, MN

  8. A Study To Evaluate 68Ga- PSMA-Dual Contrast PET/MRI And PET/CT For Hepatocellular Carcinoma

    Rochester, MN

  9. A Clinical And Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma

  10. A Study Of STX-0712 In Patients With Advanced Hematologic Malignancies

    Rochester, MN

.

Mayo Clinic Footer